A Prospective, Pilot Evaluation of Device Equivalence
Equivalence
Validation of MolecuLight Phoenix Prototypes in Clinic
1 other identifier
observational
50
1 country
1
Brief Summary
Patients with chronic wounds will be imaged using 3 imaging devices. Two types of images will be acquired with each device, as standard photograph (ST-image) and a fluorescence image (FL-image). The images captured with the 3 imaging devices will be compared off-line by 5 interpreters to assess for any differences in the images that would alter a clinical decision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2018
CompletedStudy Start
First participant enrolled
November 26, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2019
CompletedDecember 3, 2019
November 1, 2019
1 month
November 22, 2018
November 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Concordance
Estimate concordance of moderate/heavy bacterial load present in images acquired with each of 3 devices
2 months
Interventions
Hand-held, real-time fluorescence imaging device
Eligibility Criteria
patients with chronic wounds
You may qualify if:
- Subjects (inpatient/outpatient) presenting with a wound
- Wound size less than 15 cm in length
- years or older
You may not qualify if:
- Treatment with an investigational drug within 1 month before study enrolment
- Subjects with recent (\<30 days) biopsy or curettage of target wound
- Subjects with wounds that cannot be completely imaged by study device due to anatomic location
- Unable or unwilling to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MolecuLight Inc.lead
Study Sites (1)
Judy Dan Research and Treatment Centre
North York, Ontario, M2R 1N5, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Ron Linden, MD
Judy Dan Research and Treatment Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2018
First Posted
November 27, 2018
Study Start
November 26, 2018
Primary Completion
January 2, 2019
Study Completion
January 2, 2019
Last Updated
December 3, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
There is no plan to disseminate information to patients. If patients ask for their information then they will be provided a response with the most up to date information.